纳米乳液在皮肤癌治疗中:一个有前途的前沿领域
Biswajit Basu1, Ayon Dutta2, Dipanjana Ash3
1Department of Pharmaceutical Technology, School of Health & Medical Sciences, Adamas University, Barasat, Kolkata, West Bengal, 700126. India.
Current pharmaceutical biotechnology
|July 23, 2024
概括
纳米乳液显示为局部皮肤癌治疗的前景,有效地提供抗癌药物. 然而,生理障碍限制了它们的透,目前的应用仅限于临床前研究.
科学领域:
- 皮肤病学 皮肤病学
- 纳米技术纳米技术
- 制药科学 制药科学
背景情况:
- 皮肤癌,包括黑色素瘤和非黑色素瘤类型,对全球健康构成重大挑战.
- 目前的化疗,免疫疗法和手术等治疗方法通常只适用于严重病例.
- 纳米技术提供了新的治疗策略,纳米乳液成为有前途的局部药物输送系统.
研究的目的:
- 探索纳米乳液作为皮肤癌治疗中抗质药物的局部纳米载体的潜力.
- 评估纳米乳液的优势,包括提高生物可用性和向药物输送.
- 在临床前皮肤癌模型中确定与纳米乳液透相关的局限性和挑战.
主要方法:
- 使用纳米乳液,一种稳定的油,水和表面活性剂的合分散,用于药物输送.
- 调查纳米乳液对活跃和被动瘤向的能力.
- 通过透性保留效应来评估提高生物可用性.
主要成果:
- 纳米乳液显示出控制和持续向皮肤癌细胞递送药物的潜力.
- 这些系统可以提高药物的生物可用性,并最大限度地减少不良影响.
- 临床前研究表明,生理因素可以阻碍纳米乳液局部透.
结论:
- 纳米乳液代表了一种可行的纳米载体,用于在皮肤癌中提供局部抗癌药物.
- 需要进一步的研究来克服透障碍并提高临床疗效.
- 优化纳米乳液配方对于成功转化到临床应用至关重要.
相关概念视频
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


